[breadcrumb_custom]

Agilon Health Inc (AGL)’s Stock Performance and Outlook

In the latest trading session, 0.97 million Agilon Health Inc (NYSE:AGL) shares changed hands as the company’s beta touched 0.53. With the company’s most recent per share price at $7.19 changing hands around $0.37 or 5.43% at last look, the market valuation stands at $2.92B. AGL’s current price is a discount, trading about -309.46% off its 52-week high of $29.44. The share price had its 52-week low at $5.63, which suggests the last value was 21.7% up since then. When we look at Agilon Health Inc’s average trading volume, we note the 10-day average is 6.01 million shares, with the 3-month average coming to 0.83.

Agilon Health Inc (NYSE:AGL) trade information

Instantly AGL is in green as seen in intraday trades today. With action 23.75%, the performance over the past five days has been green. The jump to weekly highs of 7.52 added 5.43% to the stock’s daily price. The company’s shares are showing year-to-date downside of -42.71%, with the 5-day performance at 23.75% in the green. However, in the 30-day time frame, Agilon Health Inc (NYSE:AGL) is -9.45% down. Looking at the short shares, we see there were 44.75 million shares sold at short interest cover period of 5.45 days.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.
Sponsored

Agilon Health Inc (AGL) estimates and forecasts

Data shows that the Agilon Health Inc share is performing relatively much not better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -61.57% over the past 6 months, a -26.92% in annual growth rate that is considerably lower than the industry average of 4.70%. Moreover, analysts have looked to lower expectations by upgrading its fiscal year 2024 revenue estimates. The rating firms predict current quarter revenue for Agilon Health Inc will fall -92.90%, while the growth in revenue is estimated to hit -25.00% for the next quarter. Year-over-year growth is forecast to reach 65.80% up from the last financial year.

Consensus estimates given by 15 financial analysts project the company’s revenue in the current quarter to hit an average of $1.02 billion. 10 analysts are of the opinion that Agilon Health Inc’s revenue for the quarter ending Mar 2024 will be $1.57 billion. The company’s revenue for the corresponding quarters a year ago was $689.77 million and $1.14 billion respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 47.70%. The estimates for the next quarter sales put growth at 37.80%.

Agilon Health Inc (NYSE:AGL)’s Major holders

If we look at who the major shareholders are, we find that insiders hold 1.13% of Agilon Health Inc shares while 112.50% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 113.79%. There are 112.50% institutions holding the Agilon Health Inc stock share, with Clayton, Dubilier & Rice, LLC the top institutional holder. As of Jun 29, 2023, the company held 24.66% of the shares, roughly 100.0 million AGL shares worth $1.73 billion.

FMR, LLC holds the second largest percentage of outstanding shares, with 14.99% or 60.78 million shares worth $1.05 billion as of Jun 29, 2023.

Among Mutual Funds, the top two as of Jun 29, 2023 were New Economy Fund (The) and Vanguard Specialized-Health Care Fund. With 19.77 million shares estimated at $342.87 million under it, the former controlled 4.88% of total outstanding shares. On the other hand, Vanguard Specialized-Health Care Fund held about 4.70% of the shares, roughly 19.04 million shares worth around $364.67 million.

On Key

Related Posts